Neurosteroids: Molecular mechanisms of action and psychopharmacological significance

Journal of Steroid Biochemistry and Molecular Biology

Volumn 56, Issue 1-6, 1996, Pages 163-168

  Rupprecht, Rainer ^a   Hauser, Charlotte A E ^a   Trapp, Thorsten ^a   Holsboer, Florian ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID; ION CHANNEL; PROGESTERONE RECEPTOR; TETRAHYDRODEOXYCORTICOSTERONE;

ANIMAL EXPERIMENT; ANXIETY; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NERVE EXCITABILITY; NONHUMAN; RAT; SLEEP;

EID: 0029919873     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(95)00233-2     Document Type: Conference Paper

References (50)

1. Evans R. M.: The steroid and thyroid hormone receptor superfamily. Science 240 (1988) 889-895.
2. McEwen B. S.: Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 12 (1991) 141-147.
3. Schumacher M.: Rapid membrane effects of steroid hormones: an emerging concept in neuroendocrinology. Trends Neurosci. 13 (1990) 359-362.
4. Baulieu E. E.: Neurosteroids: a new function in the brain. Biol. Cell. 71 (1991) 3-10.
5. Costa E., Auta J., Guidotti A. and Korneyev A.: The pharmacology of neurosteroidogenesis. J. Steroid Biochem. Molec. Biol. 49 (1994) 385-389.
6. Celotti F., Melcangi R. C. and Martini L.: The 5α-reductase in the brain: molecular aspects and relation to brain function. Front. Neuroendocr. 13 (1992) 163-215.
7. Krause J. E. and Karavolas H. J.: Pituitary 5α-dihydroprogesterone 3α-hydroxysteroid-oxidoreductases. J. Biol. Chem. 255 (1980) 11,807-11,814.
8. Rupprecht R., Reul J. M. H. M., Trapp T., van Steensel B., Wetzel C., Damm K., Zieglgansberger W. and Holsboer F.: Progesterone receptor-mediated effects of neuroactive steroids. Neuron 11 (1993) 523-530.
9. Majewska M. D., Harrison N. L., Schwartz R. D., Barker J. L. and Paul S. M.: Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 (1986) 1004-1007.
10. Paul S. M. and Purdy R. H.: Neuroactive steroids. FASEB J. 6 (1992) 2311-2322.
11. Majewska M. D., Demigoren S., Spivak C. E. and London E. D.: The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res. 526 (1990) 143-146.
12. Majewska M. D., Mienville J.-M. and Vicini S.: Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons. Neurosci. Lett. 90 (1988) 279-284.
13. Carl P., Högskilde S., Nielsen J. W., Sorensen M. B., Lindholm M., Karlen B. and Backstrom T.: Pregnanolone emulsion: a preliminary pharmacokinetic and pharmacodynamic study of a new intravenous agent. Anaesthesia 45 (1990) 189-197.
14. Dennerstein L., Spencer-Gardner C., Gotts G., Brown J, B., Smith M. A. and Burrows G. D.: Progesterone and the premenstrual syndrome: a double blind crossover trial. Br. Med. J. 290 (1980) 1617-1621.
15. Smith S. S.: Progesterone enhances inhibitory responses of cerebellar Purkinje cells mediated by the GABAA receptor subtype. Brain Res. Bull. 23 (1989) 317-322.
16. Schweizer E., Case W. G., Garcia-Espana F., Greenblatt D. J. and Rickels K.: Progesterone coadministration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcome. Psychopharmacol. 117 (1995) 424-429.
17. Mendelson W. B., Martin J. V., Perlis M., Wagner R., Majewska M. D. and Paul S. M.: Sleep induction by an adrenal steroid in the rat. Psychopharmacol. 93 (1987) 226-229.
18. Crawley J. N., Glowa J. R., Majewska M. D. and Paul S. M.: Anxiolytic activity of an endogenous adrenal steroid. Brain Res. 398 (1986) 382-385.
19. Patchev V. K., Shoaib M., Holsboer F. and Almeida O. F. X.: The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience 62 (1994) 265-271.
20. Wieland S., Lan N. C., Mirasedeghi S. and Gee K. W.: Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-o1-20-one. Brain Res. 565 (1991) 263-268.
21. A receptor. Brain Res. 561 (1991) 157-161.
22. Wieland S., Belluzi J. D., Stein L. and Lan N. C.: Comparative behavioral characterization of the neuroactive steroids 3α-OH,5α-pregnan-20-one and 3α-OH,5β-pregnan-20-one in rodents. Psychopharmacol. 118 (1995) 65-71.
23. A-receptor modulation. Brain Res. 615 (1993) 267-274.
24. Lancel M., Cronlein T. A. M., Muller-Preuß P. and Holsboer F.: Pregnenolone enhances EEG delta activity during non-rapid eye movement sleep in the rat in contrast to midazolam. Brain Res. 646 (1994) 85-94.
25. Friess E., Trachsel L., Guldner J., Schier T., Steiger A. and Holsboer F.: DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. Am. J. Physiol. 268 (1995) E107-E113.
26. Flood J. F., Smith G. E. and Roberts E.: Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res. 447 (1988) 269-278.
27. A receptors. Neuron 4 (1990) 759-765.
28. A receptors by neuroactive steroids. Eur. J. Pharmacol. Molec. Pharmacol. Section 289 (1995) 249-257.
29. Morrow A. L., Pace J. R., Purdy R. H. and Paul S. M.: Characterization of steroid interactions with γ-aminobutyric acid receptor-gated chloride ion channels: evidence for multiple steroids recognition sites. Molec. Pharmacol. 37 (1990) 263-270.
30. Lan N. C., Gee K. W., Bolger M. B. and Chen J. S.: Differential responses of expressed recombinant human γ-aminobutyric acid A receptors to neurosteroids. J. Neurochem. 57 (1991) 1818-1821.
31. A receptor on the response to a neurosteroid. Eur. J. Pharmacol. 206 (1991) 77-80.
32. Wu F.-S., Gibbs T. T. and Farb D. H.: Inverse modulation of γ-aminobutyric acid- and glycine-induced currents by progesterone. Molec. Pharmacol. 37 (1990) 597-602.
33. Wu F.-S., Gibbs T. T. and Farb D. H.: Pregnenolone sulfate: A positive allosteric modulator at the N-methyl-D-aspartate receptor. Molec. Pharmacol. 40 (1991) 333-336.
34. Bowlby M. R.: Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. Molec. Pharmacol. 43 (1993) 813-819.
35. Purdy R. H., Morrow A. L., Blinn J. R. and Paul S. M.: Synthesis, metabolism, and pharmacological activity of 3α-hydroxy steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptosomes. J. Med. Chem. 33 (1990) 1572-1581.
36. Gee K. W., Bolger M. B., Brinton R. E., Coirini H., McEwen B. S.: Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J. Pharmacol. Exp. Ther. 246 (1988) 803-812.
37. Hollenberg S. M. and Evans R. M.: Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 55 (1988) 899-906.
38. Hollenberg S. M., Weinberger C., Ong E. S., Cerelli G., Oro A., Lebo R., Thompson E. B., Rosenfeld M. G. and Evans R. M.: Primary structure and expression of a functional glucocorticoid receptor cDNA. Nature 318 (1985) 635-641.
39. Arriza J. L., Weinberger C., Cerelli G., Glaser T. M., Handelin B. L., Housman D. E. and Evans R. M.: Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237 (1987) 268-275.
40. Conneely O. M., Kettelberger D. M., Tsai M. J., Schrader W. T. and O'Malley B. W.: The chicken progesterone receptor A and B isoforms are products of an alternate translation event. J. Biol. Chem. 264 (1989) 14,062-14,064.
41. Kastner P., Bocquel M., Turcotte B. P., Gamier J. M., Horwitz K. B., Chambon B. and Gronemeyer H.: Transient expression of human and chicken progesterone receptors does not support alternative translation initiation from a single mRNA as the mechanism generating two receptor isoforms. J. Biol. Chem. 265 (1990) 12,163-12,167.
42. Denner L. A., Weigel N. L., Maxwell B., Schrader W. T. and O'Malley B. W.: Regulation of progesterone receptor-mediated transcription by phosphorylation. Science 250 (1990) 1740-1743.
43. Power R. F., Mani S. K., Codina J., Conneely O. M. and O'Melley B. W.: Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254 (1991) 1636-1639.
44. Purdy R. H., Morrow A. L., Moore P. H. and Paul S. M.: Stress-induced elevations of γ-aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Natn. Acad. Sci. U.S.A. 8 (1991) 4553-4557.
45. Sarrieau A., Dussaillant M., Agid F., Philibert D., Agid Y. and Rostene W.: Autoradiographic localization of glucocorticosteroid and progesterone binding sites in the human post mortem brain. J. Steroid Biochem. 25 (1986) 717-721.
46. Fox S. R., Harlan R. E., Shivers B. D. and Pfaff D. W.: Chemical characterization of neuroendocrine targets for progesterone in the female rat brain and pituitary. Neuroendocrinology 51 (1990) 276-283.
47. A receptors. FASEB J. 4 (1990) 1469-1480.
48. Melcangi R. C., Celotti F., Castano P. and Martini L.: Differential localization of the 5α-reductase and the 3α-hydroxysteroid dehydrogenase in neuronal and glial cultures. Endocrinology 132 (1993) 1252-1259.
49. A receptors. Drug News Perspect. 5 (1992) 145-152.
50. Holsboer F.: Hormones and brain function. In New Pharmacological Approaches to the Therapy of Depressive Disorders (Edited by J. Mendlewicz, N. Brunello, S. Z. Langer and G. S. Racagni). Karger, Basel (1993) pp. 164-176.